Explore comprehensive treatments for CIDP, including corticosteroids, plasma exchange, immunoglobulin therapy, and others.

Learn the key differences between CIDP and GBS, including causes, onset, and treatments, to ensure you get the correct ...

Tanruprubart MAA Filed with Potential to Be the First Targeted Fast-Acting Therapy for Guillain-Barré Syndrome (GBS); BLA Submission with U.S./European Data Planned in 2026 Vonaprument Pivotal Phase 3 ...

Potential to Be the First Targeted Fast-Acting Therapy for GBS, Setting a New Standard of Care BLA Submission with U.S./European Data from ...

AOM Infusion (“AOM”), a leading provider of specialty infusion and pharmacy services for chronic and complex conditions, has been selected by Kedrion Biopharma as a limited distribution network ...

The fetus received IVIG, two intrauterine transfusions and four therapeutic plasma exchanges over the course of the pregnancy. A case report and literature review published in the Journal of Perinatal ...

The researcher's goal was to assess the LLM's ability to classify factors important for weaning patients off IVIG treatment, using data gathered over 2 months from 14 neurology outpatients treated ...

Objective To compare the disease course in patients with mild Guillain-Barré syndrome (GBS) who were treated with intravenous immunoglobulin (IVIg) or supportive care only. Methods We selected ...

Autoimmune disorders occur when the body’s immune system cannot differentiate between cells that are its own and pathogens. Consequently, the body’s immune system attacks itself causing inflammation ...

OKLAHOMA CITY (KFOR) – An Oklahoma mother and her son are pleading with their health insurance company to cover the only treatment that has brought relief to a young man suffering a rare and ...

QIVIGY is the realization of over 10 years of investments and internal efforts to bring a proprietary IVIG product from concept to commercialization FORT LEE, N.J., Sept. 29, 2025 /PRNewswire/ -- ...